Amphetamine administration does not alter protein levels of the GLT-1 and EAAC1 glutamate transporter subtypes in rat midbrain, nucleus accumbens, striatum, or prefrontal cortex

Molecular Brain Research

Volumn 90, Issue 2, 2001, Pages 187-192

  Sidiropoulou, Kyriaki ^a   Chao, Steven ^a   Lu, Wenxiao ^a   Wolf, Marina E ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Behavioral sensitization; Glutamate transmisssion; Neuronal plasticity; Stimulant; Substantia nigra; Ventral tegmental area

Indexed keywords

ACTIN; AMPA RECEPTOR; AMPHETAMINE; CARRIER PROTEIN; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; ISOPROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN EAAC1; PROTEIN GLT 1; RECEPTOR SUBUNIT; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADAPTATION; AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; DRUG WITHDRAWAL; IMMUNOBLOTTING; LONG TERM EXPOSURE; MALE; MESENCEPHALON; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TREATMENT OUTCOME;

AMINO ACID TRANSPORT SYSTEM X-AG; AMPHETAMINE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; BRAIN CHEMISTRY; CARRIER PROTEINS; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; EXCITATORY AMINO ACID TRANSPORTER 3; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; GLUTAMIC ACID; MALE; NEURONAL PLASTICITY; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; SYMPORTERS; VENTRAL TEGMENTAL AREA;

EID: 0035919130     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(01)00110-3     Document Type: Article

References (51)

1. Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens
2. Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease - An in situ hybridization study
3. Free radicals and the pathobiology of brain dopamine systems
4. Phosphorylation and modulation of brain glutamate transporters by protein kinase C
5. Repeated cocaine alters glutamate receptor subunit levels in the nucleus accumbens and ventral tegmental area of rats that develop behavioral sensitization
6. Inhibition of the high-affinity brain glutamate transporter GLAST-1 via direct phosphorylation
7. EAAC1, a high-affinity glutamate transporter is localized to astrocytes and gabaergic neurons besides pyramidal cells in the rat cerebral cortex
8. Multiple signaling pathways regulate cell surface expression and activity of the excitatory amino acid carrier 1 subtype of Glu transporter in C6 glioma
9. Functional diversity of excitatory amino acid transporters: Ion channel and transport modes
10. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: Common adaptations among cross-sensitizing agents
11. Cellular and synaptic localization of the neuronal glutamate transporters excitatory amino acid transporter 3 and 4
12. Modulation of human glutamate transporter activity by phorbol ester
13. High affinity glutamate transporters: Regulation of expression and activity
14. Cellular distribution and kinetic properties of high-affinity glutamate transporters
15. Neuroadaptations in ionotropic and metabotropic glutamate receptor mRNA produced by cocaine treatment
16. Compensatory change in EAAC1 glutamate transporter in rat hippocampus CA1 region during kindling epileptogenesis
17. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity
18. Decreased glutamate transporter (GLT-1) expression in frontal cortex of rats with acute liver failure
19. Repeated amphetamine administration alters the expression of mRNA for AMPA receptor subunits in rat nucleus accumbens and prefrontal cortex
20. Withdrawal from repeated amphetamine administration reduces NMDAR1 expression in the rat substantia nigra, nucleus accumbens and medial prefrontal cortex
21. Repeated amphetamine administration alters AMPA receptor subunit expression in rat nucleus accumbens and medial prefrontal cortex
22. Hypoxia-ischemia causes abnormalities in glutamate transporters and death of astroglia and neurons in newborn striatum
23. Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy
24. Alterations in glutamate transporter protein levels in kindling-induced epilepsy
25. EAAT4, a glutamate transporter with properties of a chloride channel, is predominantly localized in Purkinje cell dendrites, and forms parasagittal compartments in rat cerebellum
26. The glial glutamate transporter in hyperammonemia and hepatic encephalopathy: Relation to energy metabolism and glutamatergic neurotransmission
27. Traumatic brain injury down-regulates glial glutamate transporter (GLT-1 and GLAST) proteins in rat brain
28. Glial glutamate transporter GLT-1 down-regulation precedes delayed neuronal death in gerbil hippocampus following transient global cerebral ischemia
29. The family of sodium-dependent glutamate transporters: A focus on the GLT-1/EAAT2 subtype
30. Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
31. Localization of neuronal and glial glutamate transporters
32. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis
33. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate
34. Chronic neuroleptic treatment alters expression of glial glutamate transporter GLT-1 mRNA in the striatum
35. Excitatory amino acid transporters: A family in flux
36. Increased striatal glutamate transporter by repeated intermittent administration of methamphetamine
37. Platelet-derived growth factor rapidly increases activity and cell surface expression of the EAAC1 subtype of glutamate transporter through activation of phosphatidylinositol 3-kinase
38. +-dependent glutamate transporter: Pharmacological characterization and lack of regulation by protein kinase C
39. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1
40. Functions of glutamate transporters in the brain
41. Reduced postischemic expression of a glial glutamate transporter, GLT1, in the rat hippocampus
42. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: A critical review of preclinical studies
43. Motor discoordination and increased susceptibility to cerebellar injury in GLAST mutant mice
44. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants
45. Amphetamine and D1 dopamine receptor agonists produce biphasic effects on glutamate efflux in rat ventral tegmental area: Modification by repeated amphetamine administration
46. Amphetamine-induced glutamate efflux in the rat ventral tegmental area is prevented by MK-801, SCH 23390, and ibotenic acid lesions of the prefrontal cortex
47. Amphetamine increases glutamate efflux in the rat ventral tegmental area by a mechanism involving glutamate transporters and reactive oxygen species
48. Acute and repeated systemic amphetamine administration: Effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens
49. EAAT4 is a post-synaptic glutamate transporter at Purkinje cell synapses
50. Amphetamine neurotoxicity: Roles for dopamine, glutamate and oxidative stress
51. Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors